HCV Symposium 2011

2011 年丙型肝炎研讨会

• 批准号: 8128005
• 负责人: STEPHEN J. POLYAK
• 金额: $ 2.3万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8128005
• 关键词: Acute Hepatitis C; Africa; Antiviral Therapy; Asia; Awareness; Chronic; Chronic Hepatitis C; Cirrhosis; Country; Development; Disease; Education; Ensure; Epidemic; Europe; Fostering; Funding; Future; Genetic; Goals; Hepatitis; Hepatitis C; Hepatitis C virus; Immune response; Immunology; India; Infection; Interferons; International; Latin America; Lead; Life; Liver diseases; Malignant neoplasm of liver; Molecular Virology; Pathogenesis; Patients; Pharmaceutical Preparations; Prevention; Research; Research Personnel; Ribavirin; Risk; Scholarship; Scientist; Societies; Travel; United States National Institutes of Health; Virus; Virus Diseases; ethnic minority population; improved; interest; meetings; novel strategies; symposium; virology

DESCRIPTION (provided by applicant): Hepatitis C Virus (HCV) infects over 150 million people throughout the world and is a leading cause of liver disease (1). After discovery of the virus in 1989, the International Symposium on Hepatitis C Virus and Related Viruses (hereafter referred to as HCV Symposium) was founded in 1992 with the goals of increasing the scientific understanding of the virus, the disease, and to develop novel approaches for controlling its spread. The HCV Symposium is the leading international meeting for scientists and clinicians interested in the molecular virology, pathogenesis, prevention and treatment of chronic hepatitis C. In September 2011, over 800 researchers from around the world will congregate in Seattle, WA, to attend the 18th HCV Symposium. One long-term goal of the Symposium is to ensure the future of the meeting by expanding international awareness of the Symposium, and to attract scientists from countries that historically have not attended the Symposium. As part of these efforts, the Seattle organizing committee is obtaining endorsements from liver disease research societies in the USA, Europe, India, Latin America, Asia, and Africa. Therefore, this R13 application seeks NIH support for the Symposium, so that we can offer travel scholarships to investigators from under-represented countries and ethnic minorities. NIH support will facilitate education and research in under- represented countries where the HCV epidemic continues unabated. Ultimately, support of the HCV Symposium will lead to improved global control of hepatitis C. PUBLIC HEALTH RELEVANCE: This application seeks to obtain funding to support the 18th International Symposium on Hepatitis C Virus and Related Viruses, to be held in Seattle, WA, USA, from September 8-12, 2011. The HCV Symposium is a world- class meeting focused on the virology, immunology, disease, and treatment of hepatitis C. NIH funds will be used to support the travel to and attendance at HCV2011 of scientists from under-represented countries.

描述（由申请人提供）：丙型肝炎病毒（HCV）在世界范围内感染了1.5亿人，是肝病的主要原因（1）。 1989年发现该病毒后，关于丙型肝炎病毒和相关病毒的国际研讨会（以下称为HCV研讨会）成立于1992年，其目标是增加对病毒，疾病的科学理解，并开发用于控制其传播的新颖方法。 HCV研讨会是对科学家和临床医生的主要国际会议，对分子病毒学，发病机理，预防和治疗的慢性乙型肝炎。2011年9月，来自世界各地的800多名研究人员将在华盛顿州西雅图市的800多名研究人员参加第18届HCV研讨会。研讨会的一个长期目标是通过扩大国际对研讨会的认识来确保会议的未来，并吸引从历史上没有参加研讨会的国家的科学家。作为这些努力的一部分，西雅图组织委员会正在获得美国，欧洲，印度，拉丁美洲，亚洲和非洲的肝病研究社会的认可。因此，该R13申请寻求NIH对研讨会的支持，以便我们可以向来自代表性不足的国家和少数民族的调查人员提供旅行奖学金。 NIH的支持将促进HCV流行持续不断减弱的不足国家的教育和研究。最终，对HCV研讨会的支持将改善对肝炎的全球控制。 PUBLIC HEALTH RELEVANCE: This application seeks to obtain funding to support the 18th International Symposium on Hepatitis C Virus and Related Viruses, to be held in Seattle, WA, USA, from September 8-12, 2011. The HCV Symposium is a world- class meeting focused on the virology, immunology, disease, and treatment of hepatitis C. NIH funds will be used to support the travel to and attendance at HCV2011 of scientists from代表性不足的国家。